U.S. Agencies Allege Alibaba Used Fake Accounts and Prompt-Injection to Extract AI Capabilities
BABA sits 18% above its 52-week low of $91.99.
Summary
U.S. agencies now allege Alibaba used fake accounts, bulk API calls, and prompt-injection since late 2024 to extract U.S. AI model capabilities, potentially speeding Chinese firms' AI development. This escalates the June 25 Anthropic accusation by adding government involvement and specific methods. The alleged distillation campaign from May–July used Claude outputs to train Qwen models. The news adds regulatory and legal risk to Alibaba's AI ambitions, which are already under scrutiny following the Pentagon designation dispute and the $600M DOJ settlement.
At the time of this announcement, BABA was trading at $108.55 on NYSE in the Technology sector, with a market capitalization of approximately $271B. The 52-week trading range was $91.99 to $192.67. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Wiseek News.